SecBot SecBot
8-K ·Filed Nov 9, 2026

ABEO

ABEONA THERAPEUTICS INC.
BEARISH
Impact 6/10
Horizonweeks Processed7d 19h ago SEC0001493152-26-050606
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

The PIPE funds the asset acquisition and provides working capital, but the activist presence (6.1% stake, requesting board changes) combined with the dilutive financing suggests the company is under pressure to execute. Monitor the registration statement filing (due within 15 days) and any further activist communications regarding board composition or strategic alternatives.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$2.54
T+0 close · Nov 9, 2026 · via day close
Latest settled
+2.36%
T+5 · $2.60
Vs SPY
+4.05%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $2.54entry
  2. T+1 · 7d ago −3.35%α −2.98% · $2.46
  3. T+5 · 19h ago +2.36%α +4.05% · $2.60
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Abeona Therapeutics entered into a securities purchase agreement with institutional investors to sell up to 8,000,043 shares and/or pre-funded warrants at $3.75 per share, raising approximately $30M in gross proceeds. Simultaneously, the company completed an asset acquisition from Ellodi Pharmaceuticals for $20M in stock, funded by the PIPE. The combined transactions dilute existing shareholders by roughly 13-15% based on the $224M market cap, while the activist stake (6.1%) filed 17 days ago adds pressure for strategic change.

Key Financial Metrics

Deal Value
$20.0M
Deal Type
acquisition
Offering Size
$30.0M

Key Facts

  • PIPE of up to 8,000,043 shares/pre-funded warrants at $3.75/share, raising ~$30M
  • Asset purchase from Ellodi Pharmaceuticals for $20M in stock (upfront shares)
  • Activist James Russell disclosed 6.1% stake 17 days prior, requesting board changes
  • Morgan Stanley acted as placement agent
  • Registration rights agreements filed for both PIPE shares and Ellodi consideration shares
  • Pre-funded warrants have $0.0001 exercise price, effectively deep-in-the-money

Financial Impact

~$30M PIPE gross proceeds; $20M stock consideration for asset acquisition; dilution of ~13-15% of shares outstanding based on $224M market cap

dilutioncashdebt

Risk Factors

  • Dilution of ~13-15% from the combined PIPE and asset acquisition stock issuance
  • Activist may escalate to proxy contest if board changes are not addressed
  • Asset acquisition integration risk and potential cash burn from Ellodi assets
  • Overhang from potential resale of registered shares by PIPE investors and Ellodi

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-050606
Exhibit: ex4-3.htm0001493152-26-050606
Exhibit: ex4-1.htm0001493152-26-050606
Exhibit: ex4-2.htm0001493152-26-050606

Track record

29 reports on ABEO

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 3 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $2.59 Now $2.60 +0.39% settles Nov 18
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
  4. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  5. Nov 9, 20267d ago 8-K Bearish 6/10 Viewing Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
  6. Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  7. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
  8. Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
  9. Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
  10. Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens in 7h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026